Subsequent Therapies Post-Afatinib Among Patients With Egfr Mutation-Positive (Egfrm Plus ) Nsclc In Lux-Lung 3, 6 And 7L. V. Sequist,Y. Wu, M. Schuler,T. Kato,J. C. Yang,H. Tanaka,T. Hida,S. Lu,K. Park, L. Paz-Ares,S. Laurie,J. Bennouna,D. Moro Sibilot, A. Maerten,W. Tang, E. Ehrnrooth,N. Yamamoto,K. NakagawaJOURNAL OF THORACIC ONCOLOGY(2017)引用 4|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要